234 related articles for article (PubMed ID: 1999656)
1. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje.
Van den Berg CW; Aerts PC; Van Dijk H
J Immunol Methods; 1991 Feb; 136(2):287-94. PubMed ID: 1999656
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage.
von Zabern I; Hinsch B; Przyklenk H; Schmidt G; Vogt W
Immunobiology; 1980 Dec; 157(4-5):499-514. PubMed ID: 6905795
[TBL] [Abstract][Full Text] [Related]
3. Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.
Cheung AK; Parker CJ; Wilcox L
Clin Exp Immunol; 1989 Nov; 78(2):299-306. PubMed ID: 12412765
[TBL] [Abstract][Full Text] [Related]
4. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
[TBL] [Abstract][Full Text] [Related]
5. Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse system.
Van den Berg CW; Aerts PC; Van Dijk H
J Immunol Methods; 1990 Oct; 133(2):199-206. PubMed ID: 2230138
[TBL] [Abstract][Full Text] [Related]
6. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
Hodgetts SI; Grounds MD
Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
[TBL] [Abstract][Full Text] [Related]
7. Antigenic relationships between human and cobra complement factors C3 and cobra venom factor (CVF) from the Indian cobra (Naja naja).
Eggertsen G; Lundwall A; Hellman U; Sjöquist J
J Immunol; 1983 Oct; 131(4):1920-3. PubMed ID: 6194220
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of a complement-depleting factor from king cobra, Ophiophagus hannah.
Zeng L; Sun QY; Jin Y; Zhang Y; Lee WH; Zhang Y
Toxicon; 2012 Sep; 60(3):290-301. PubMed ID: 22561424
[TBL] [Abstract][Full Text] [Related]
9. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.
Till GO; Morganroth ML; Kunkel R; Ward PA
Am J Pathol; 1987 Oct; 129(1):44-53. PubMed ID: 3661679
[TBL] [Abstract][Full Text] [Related]
10. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
[TBL] [Abstract][Full Text] [Related]
11. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
13. Naja melanoleuca cobra venom contains two forms of complement-depleting factor (CVF).
Osipov AV; Mordvintsev DY; Starkov VG; Galebskaya LV; Ryumina EV; Bel'tyukov PP; Kozlov LV; Romanov SV; Doljansky Y; Tsetlin VI; Utkin YN
Toxicon; 2005 Sep; 46(4):394-403. PubMed ID: 16054663
[TBL] [Abstract][Full Text] [Related]
14. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase.
Fu Q; McPhie P; Gowda DC
Biochem Mol Biol Int; 1998 Jun; 45(1):133-44. PubMed ID: 9635137
[TBL] [Abstract][Full Text] [Related]
15. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
16. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
Vogel CW; Fritzinger DC
Curr Pharm Des; 2007; 13(28):2916-26. PubMed ID: 17979736
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of three medically important Nigerian Naja (Naja haje, Naja katiensis and Naja nigricollis) snake venoms.
Adamude FA; Dingwoke EJ; Abubakar MS; Ibrahim S; Mohamed G; Klein A; Sallau AB
Toxicon; 2021 Jul; 197():24-32. PubMed ID: 33775665
[TBL] [Abstract][Full Text] [Related]
19. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
[TBL] [Abstract][Full Text] [Related]
20. Derivatives of human complement component C3 for therapeutic complement depletion: a novel class of therapeutic agents.
Fritzinger DC; Hew BE; Lee JQ; Newhouse J; Alam M; Ciallella JR; Bowers M; Gorsuch WB; Guikema BJ; Stahl GL; Vogel CW
Adv Exp Med Biol; 2008; 632():293-307. PubMed ID: 19025130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]